Almac Offers Expedited IRT Solutions for COVID-19 Trials

Launches the expedited deployment and support of multiple Interactive Response Technology (IRT) solutions in support of COVID-19 treatments

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Almac Clinical Technologies, a member of the Almac Group, has launched the expedited deployment and support of multiple Interactive Response Technology (IRT) solutions in support of COVID-19 treatments. Several clinical trial sponsors have recently entrusted Almac in order to support expedited pathways to emergency clinical trials designed to investigate the efficacy of investigational medicinal products and commercially pre-approved medicinal products to reduce the impact of the novel COVID-...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters